Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...

The team tested mvGPT on human liver cells with a mutation causing Wilson's disease, successfully editing out the mutation while also upregulating a gene linked to type I diabetes treatment and ...

Scientists from a collaboration of Australian research institutions have proposed that editing multiple genetic variants in ...

Gene editing is now reaching the mainstream ... which include liver damage and neurological problems. For Type I diabetes, mvGPT upregulated the expression of the gene that plays a crucial ...

The "CRISPR-based Gene Editing Market by Product & Service, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's offering.The global CRISPR-based gene editing ...

Zhang, an MIT professor and a pioneer in gene-editing technology ... of treatments for sickle cell disease, cancer, type 1 diabetes, and more,” it said. Established by Congress in 1980, the ...